An immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments have failed.
Nov 24, 2017
0
132
A long-term follow up of people on an international clinical trial has confirmed the benefit of immunotherapy for certain patients with advanced (stage 3 or 4) melanoma.
Feb 25, 2015
0
72
Immunotherapy drugs are promising new weapons in the fight against cancer, but they are so strong that they can be toxic to the rest of the human body. The basic idea behind immunotherapy drugs is simple. Doctors inject special ...
Sep 13, 2021
0
163
An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...
Sep 18, 2020
0
34
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...
Aug 15, 2018
0
175
A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.
Mar 1, 2022
0
39
EPFL scientists have developed a cancer treatment method that destroys tumor cells using the mechanical force of our bodies' own T cells. They have just completed a proof of concept for their novel immunotherapy approach.
Nov 30, 2020
0
53
Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body's immune system detect and attack cancerous cells. Doug ...
Aug 29, 2017
0
82
Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University School of Medicine report two new forms of an older anti-cancer agent they developed appear to enhance ...
Feb 19, 2019
0
43
Sometimes too much of a good thing is not good at all. Inhibiting the function of the PD-1 protein, which blocks immune function, has shown high therapeutic efficacy in cancer immunotherapy. However, when this function is ...
Aug 9, 2022
0
2
